TRU-SENTIMENT · DeltaNeutral
TMDX Trading Analysis - 11/06/2026 05:38 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
TMDX (TransMedics Group Inc. Common Stock) at $88.30. True Sentiment Bullish, delta 40-60 call 73% / put 27%, call $2,017,220 vs put $730,905. RSI 69.5.
- Symbol
- TMDX
- Price
- $88.30
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-11-06 17:38:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Options flow via True Sentiment (Delta 40-60 only):
Call Dollar Volume: $2,017,220 (73.4%) Put Dollar Volume: $730,905 (26.6%) Total: $2,748,125
Call contracts: 3,313 vs put contracts: 265. Sentiment: Bullish. Pure directional conviction strongly favors calls, suggesting near-term upside expectations. Divergence: technicals show MACD negative and spread engine flagged "Divergence detected between technical indicators and options sentiment" — options bullish, technicals lack clear direction.
Key Statistics: TMDX
Fundamental Snapshot
Valuation
| P/E (trailing) | 15.60 |
| EPS (trailing 12 mo) | $4.43 |
| Market cap | $3.06B |
| Shares outstanding | 34.7M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 2.84 |
| 52-week low | $60.10 |
| 52-week high | $156.00 |
| Historical volatility | 51.7% |
Ownership & trading
| Institutional ownership | 74.0% |
| Average daily volume | 1.0M sh |
Reported figures; no analyst estimates.
📈 Analysis
News Headlines & Context:
TransMedics Group (TMDX) is a medical technology company focused on organ transplant systems. Based on general knowledge (not embedded data), recent relevant context includes:
- TransMedics continued to scale its Organ Care System (OCS) platform with growing adoption in heart and lung transplant centers through 2025–2026.
- Prior quarterly results showed strong revenue growth but ongoing scrutiny over transplant logistics and reimbursement dynamics.
- No specific confirmed earnings date is available in this analysis, but a fiscal year-end of 2025-12-01 suggests annual reporting cycles may introduce volatility.
- Possible catalyst: increased transplant volume and hospital utilization could support bullish positioning, aligning with the embedded options sentiment.
- Context: The strong call flow in the embedded data may reflect optimism around continued procedural growth rather than a confirmed near-term event.
Fundamental Analysis:
Based strictly on the provided FUNDAMENTALS data:
- Trailing P/E: 15.60; Trailing EPS: $4.43 — relatively low multiple vs high-growth med-tech peers.
- Market Cap: $3.06B; Shares Outstanding: 34.68M; Institutional Ownership: 74.01%.
- 52-Week Range: $60.11 to $156.00 — current price ($88.17) sits in the lower half of the annual range.
- Beta: 2.84 — high systemic risk and sensitivity to broad market moves.
- Dividend Yield: 0.00% — no income component.
- PEG Ratio, Forward P/E, Revenue Growth, Margins, ROE, Debt/Equity, and FCF are null — cannot be assessed from data.
- Analyst target mean price and consensus are null — no external analyst context provided.
- Fundamentals show a cheap earnings multiple and strong institutional base, but lack of margin/growth data creates a partial picture that diverges from the sharp technical rally and bullish options flow.
Current Market Position:
Current price from indicators: $88.17 (2026-11-06 close). Daily history shows a powerful move from $67.21 (2026-11-02) to $88.17 on 2026-11-06, a +31.2% weekly surge. Volume on 2026-11-06 was 2,380,263 vs 20-day avg of 738,775 — confirmation of breakout participation.
Minute bars (2026-11-05 open $72.49 → 2026-11-06 15:55 close $88.30) show steady intraday accumulation with late-session volume spikes (209,039 at final bar). Price held above $87.77 intraday, indicating sustained momentum into close.
Technical Analysis:
Technical Indicators
Price is above SMA 5 ($72.82), SMA 20 ($72.29), and SMA 50 ($79.61) — bullish alignment with price extended above all averages. RSI at 69.47 approaches overbought but remains under 70. MACD is negative (-1.77) with histogram -0.35, showing bearish momentum structure despite price gains (divergence). Bollinger Bands show price ($88.17) above upper band ($82.67) — expansion breakout. 30-day range: price at $88.17 is near the high ($88.44), indicating strength but proximity to local ceiling.
True Sentiment Analysis (Delta 40-60 Options):
Options flow via True Sentiment (Delta 40-60 only):
Call Dollar Volume: $2,017,220 (73.4%) Put Dollar Volume: $730,905 (26.6%) Total: $2,748,125
Call contracts: 3,313 vs put contracts: 265. Sentiment: Bullish. Pure directional conviction strongly favors calls, suggesting near-term upside expectations. Divergence: technicals show MACD negative and spread engine flagged "Divergence detected between technical indicators and options sentiment" — options bullish, technicals lack clear direction.
Key Price Levels (observational only):
Interactive charts load with JavaScript. This text is the crawlable summary.